Tyrosine Kinase Inhibitor
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Tyrosine Kinase Inhibitor, covering 2019-01-10 to 2022-08-23. Get the full timeline:
Most recent: Clinical Trial Update: FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage [Phase 2]